ClinicalTrials.Veeva

Menu

Visual Outcomes of Tecnis Symfony Opti-Blue EDOF Intraocular Lens (IOL)

C

Coastal Eye Surgeons PLLC

Status

Not yet enrolling

Conditions

Cataract

Treatments

Device: Tecnis Symfony OptiBlue/ Tecnis Symfony OptiBlue toric IOL

Study type

Interventional

Funder types

Other

Identifiers

NCT06500416
CES/OS/01/2023

Details and patient eligibility

About

Tecnis Symfony Optiblue EDOF IOL is the latest version of Tecnis Symfony IOL with a violet light filter (VLF), which blocks short-wavelength light and improves the quality of vision while minimizing visual disturbances. The present study aims to assess the visual outcomes at distance, intermediate, and near following cataract surgery and implantation of Tecnis Symfony Optiblue IOL in patients with retinal comorbidities.

Full description

Extended depth of focus (EDOF) IOLs, on the other hand, are based on the principle of creating a single-elongated focal point to enhance the depth of focus (DOF) and eliminate the overlapping of near and far images caused by traditional multifocal IOLs, thus generating a lower incidence of halos and glare. The Tecnis Symfony (Johnson & Johnson Vision) EDOF IOL incorporates a diffractive echelette design to increase the range of vision. The achromatic technology corrects chromatic aberration and increases retinal image contrast.

The latest version of the Tecnis Symfony lens (DXR00V/ZXR00V) has the OptiBlue violet light filter (VLF), which blocks short-wavelength light. Violet light filtration reduces light scatter, improving contrast and reducing nighttime visual disturbances such as halo, glare, and starbursts. As such, the present study aims to assess the visual outcomes at distance, intermediate and near following implantation of violet light filtering Tecnis Symfony Optiblue EDOF IOLs in patients with retinal comorbidities undergoing cataract surgery.

Enrollment

15 estimated patients

Sex

All

Ages

50 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with retinal comorbidities, with visual acuity potential of 20/30 or better, who wish to undergo bilateral cataract surgery and are willing to provide written informed consent and adhere to study requirements.

Exclusion criteria

  • Corneal dystrophies
  • Central corneal scarring
  • Keratoconus
  • Proliferative diabetic retinopathy
  • Exudative macular degeneration
  • Zonular weakness
  • Pseudoexfoliation
  • Fovea-involving atrophy
  • Severe dry eye
  • Amblyopia
  • Pupil abnormalities
  • Need for an IOL outside the range of +5.0 D to +34.0 D or cylinder power over 3.75 D
  • Patients who have undergone prior cataract surgery and IOL implantation in either eye; had prior corneal refractive or corneal transplantation surgery; diabetics post-vitrectomy; or who have a history of macula-off retinal detachment will also be excluded.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Tecnis Symfony OptiBlue/ Tecnis Symfony OptiBlue toric IOL
Experimental group
Description:
This prospective, non-comparative, interventional study will include 15 cataract patients (30 eyes) who will undergo femtosecond laser-assisted cataract surgery with implantation of the Tecnis Symfony OptiBlue/ Tecnis Symfony OptiBlue toric IOL in both eyes.
Treatment:
Device: Tecnis Symfony OptiBlue/ Tecnis Symfony OptiBlue toric IOL

Trial contacts and locations

1

Loading...

Central trial contact

Omar Shakir, MD, MBA; Martha Kaczynski

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems